Skip to main content

Table 2 Outcome of ovarian stimulation

From: Low dose human chorionic gonadotropin administration at the time of gonadotropin releasing-hormone agonist trigger versus 35 h later in women at high risk of developing ovarian hyperstimulation syndrome – a prospective randomized double-blind clinical trial

 

Group 1 (n = 26)

Group 2 (n = 31)

P-value

Total dose of gonadotropins (IU)

1553 ± 431

1546 ± 527

0.96

Duration of ovarian stimulation (days)

8.6 ± 1.7

8.6 ± 1.4

0.83

Oocytes (n)

18.4 ± 5.9

18.4 ± 7.7

0.99

Proportion of mature oocytes (%)

85.2 ± 10.2

79.5 ± 16.9

0.18

Fertilization rate (%)

83.3 ± 11.4

80.3 ± 12.6

0.38

Embryos transferred (n)

1.5 ± 0.5

1.7 ± 0.5

0.10

Blastocyst transfer (n, %)

24/26 (92.3)

26/31 (83.9)

0.44

Embryos frozen (n)

3.3 ± 3.0

3.4 ± 3.4

0.91

Patients with frozen embryos (n, %)

21/26 (80.8)

23/31 (74.2)

0.56